
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.540 | 8.540 | 0.000 |
Stocks | 91.290 | 91.290 | 0.000 |
Other | 0.170 | 0.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.851 | 24.527 |
Price to Book | 2.688 | 3.017 |
Price to Sales | 1.865 | 4.048 |
Price to Cash Flow | 15.821 | 16.970 |
Dividend Yield | 2.948 | 1.993 |
5 Years Earnings Growth | 5.114 | 9.514 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.130 | 95.706 |
Consumer Cyclical | 0.870 | 1.070 |
Number of long holdings: 39
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Humanwell Healthcare | CNE000000QW6 | 9.57 | 21.64 | +0.23% | |
Jiangsu Hengrui | CNE0000014W7 | 8.80 | 51.04 | +0.37% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 7.72 | 225.27 | -2.00% | |
WuXi AppTec | CNE1000031K4 | 7.60 | 63.52 | -3.83% | |
Cr Sanjiu A | CNE0000011K8 | 4.63 | 44.58 | +2.41% | |
Nhwa Pharma A | CNE100000CG8 | 4.41 | 22.19 | -1.20% | |
Jointown Pharm | CNE100000W45 | 3.33 | 5.08 | -0.20% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 3.12 | 51.30 | +0.25% | |
Yunnan Baiyao A | CNE0000008X7 | 2.82 | 56.96 | +0.26% | |
Pacific Shuanglin Bio pharmacy | CNE000000F14 | 2.82 | 21.91 | +0.32% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 583.16M | 2.21 | -5.12 | 4.17 | ||
MS Huaxin Resource Selected Mixed | 417.95M | 0.58 | -14.15 | 2.66 | ||
MS Huaxin Aggressive Growth Equity | 346.35M | 2.39 | -9.07 | 4.98 | ||
Huaxin Leading Advanced Stock | 316.65M | 6.01 | -6.14 | 7.62 | ||
Huaxin Excellent Growth Stock | 260.61M | 1.02 | -13.12 | 4.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review